Navigation Links
Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey

is supplied as a ready-to-use, injectable solution in three single-dose vial sizes of 0.5 mL (2500 U), 1.0 mL (5000 U), and 2.0 mL (10,000U).

About Solstice Neurosciences, Inc.

Founded in 2004, Solstice Neurosciences, Inc. is a biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty products. Solstice's first product, MYOBLOC, represents the only botulinum toxin type B currently available to physicians and patients worldwide. MYOBLOC is sold in the United States and approved in Canada. It is also distributed and sold in the EU as NeuroBloc. MYOBLOC is indicated for the treatment of patients with cervical dystonia (CD) to reduce the severity of abnormal head position and pain associated with CD. For more information about Solstice Neurosciences, Inc., visit www.solsticeneuro.com

About Cervical Dystonia

Cervical Dystonia (CD), also known as spasmodic torticollis, is a condition that primarily affects the muscles of the head and neck (the cervical area of the spine). Cervical dystonia is the most common dystonia requiring referral to movement disorder clinics. While the exact cause of CD is unknown, scientists believe the problem originates in the basal ganglia area of the brain that is instrumental in movement. In general, there are three main approaches to the treatment of CD: oral medications, toxin therapy and surgery.

Myobloc(R) and NeuroBloc(R) are registered trademarks of Solstice Neurosciences, Inc.

CONTACT: Diane Murray, Director-Business Operations & Communications ofSolstice Neurosciences, Inc., Toll Free, +1-866-220-5042, Direct,+1-610-864-1691, diane.murray@solsticeneuro.com

Web site: http://www.solsticeneuro.com//

Terms and conditions of use apply
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference
Post Your Comments:
(Date:12/14/2009)... SAN FRANCISCO, Dec. 14 Environmental health ... promised announcement about health hazards of bisphenol A ... behavioral changes, reproductive harm and other illnesses, in ... MD, PhD , staff scientist, Natural ... on your doctor for medical advice, FDA must ...
(Date:12/14/2009)... 14 At GeoInvesting.com, we have been tracking ... time now. Our largest hang up had been with ... fiscal June 2010 net income guidance of $11.3 million ... net income of $7.9 million, the increase in shares ... scenario, which depends upon the share price and the ...
(Date:12/14/2009)... N.J., Dec. 14 Authentidate Holding ... provider of secure Health Information Exchange and ... Care of the Carolinas ("HCC"), a home ... a durable medical equipment supplier, have selected ... and standardize processes for the completion of ...
Breaking Medicine Technology:Toxic Chemical bisphenol A Still Not Banned By FDA; Schumer, Gillibrand Call for Ban; Govt Official Warns Public 2GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4Pregnant Women Need Flu Shots 5045 1Pregnant Women Need Flu Shots 5045 2Mindful meditation shared dialogues reduce physician burnout 58212 1Mindful meditation shared dialogues reduce physician burnout 58212 2Mindful meditation shared dialogues reduce physician burnout 58212 3Mindful meditation shared dialogues reduce physician burnout 58212 4Tennessee foresters helping to return chestnuts to American forests 10072 1Tennessee foresters helping to return chestnuts to American forests 10072 2
... 18 The Leukemia & Lymphoma,Society (LLS) and Memgen ... Phase I clinical trial. The trial will use Memgen,s,ISF35, ... Based on its alliance with LLS, Memgen plans ... up to 12 patients who have 17p-, refractory or,resistant ...
... On Wednesday, June 18, 2008,at 8:30 a.m. Eastern/2:30 p.m. ... (Nasdaq: CTIC ; MTA) management team will,host a ... for,access to Phase III Zevalin(R) FIT Trial data., ... 8:30 a.m. Eastern/2:30 p.m. Central European/5:30 a.m. Pacific Time ...
Other Medicine Technology:The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 2The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial 3
(Date:12/15/2009)... release of a new report titled, “Incontinence Devices Markets Worldwide.” ... used to treat and manage urinary incontinence. , ... ... Marketstrat is pleased to announce the release of a new ... addresses world markets for clinical devices used to treat and ...
(Date:12/14/2009)... Young Adults, Attitudes and Behavior Regarding Pregnancy, Contraception, and ... -- Nearly all unmarried young adults ages 18-29 believe ... men and 86% of women) and say that it ... now (86% of men and 88% of women), according ... Prevent Teen and Unplanned Pregnancy. Even so: ,, ...
(Date:12/14/2009)... and HOLLYWOOD, Fla., Dec. 14 ... today a definitive agreement to acquire STARLIMS ... leading provider of laboratory information management systems, ... ,, The acquisition strengthens Abbott,s competitive position ... web-based applications to help laboratories efficiently store, ...
(Date:12/14/2009)... The National Organization for Rare Disorders (NORD) ... to lifetime and annual health insurance caps. In ... newspaper distributed widely on Capitol Hill, NORD said the ... allow caps to continue for most Americans, contrary to ... care reform and welcomes the promises made by President ...
(Date:12/14/2009)... years under government controlled health care, before moving to the U.S. ... and in his new book, Health Reform: The End of the ... system and its threat to real health care! , ... ... diagnostic radiologist from Minnesota, warns Americans not to sell out their ...
Breaking Medicine News(10 mins):Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 2Health News:Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail 3Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 2Health News:Although Most Unmarried Young Adults Want to Avoid Pregnancy, Many Don't Use Contraception, Know Little About It, and Think It Doesn't Make Much Difference 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:NORD Calls for Immediate End to Lifetime Insurance Caps 2Health News:Canadian Doctor Warns Against Government-Run, Socialized Medicine and its Threat to Health Care and Freedom in America 2
... The Delhi High Court, which is angered by the defence ... from the medical superintendent// about the case where a boy, ... at the hospital in 2001. ,The victim, ... admission to the hospital in July 2000 for treatment of ...
... identified a new strategy to effectively combat the West ... spread through a complex interaction// of nesting birds, mosquitoes ... believed to pave way for viral amplification with mosquito ... the University of Florida have identified how those factors ...
... Patricia Rashbrook, the psychologist and the oldest mother in UK, ... has recently remarried //and undergone fertility treatment. She gave the ... ,She and her husband John Farrant made a joint ... an endeavour undertaken lightly or without courage. A great deal ...
... to chill out. Places such as backyard pool, hot tub and ... cautious and always follow the instructions of their parents. In some ... safety measures such as installing the pool fences and pool alarms. ... install the child proof safety measures as it is small and ...
... researchers at the Aberdeen University it was found that women ... experience unnecessarily high levels of anxiety. About 3,500 women were ... Cervical cancer is on the rise in UK. ... can affect women of any age who were sexually active ...
... blueprint for handling a pandemic, state and local health officials ... of lethal influenza in the U.S. ,While the ... the risk of a pandemic and its transmission, ``the center ... communities,'' the report said. ,A preliminary $7.1 billion ...
Other Medicine News:Health News:A Boy Undergoing Treatment For Cancer Gets AIDS At AIIMS 2Health News:West Nile Virus Can Be Tackled By New Strategy 2Health News:West Nile Virus Can Be Tackled By New Strategy 3Health News:A mother at 63: oldest in UK! 2Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic 2Health News:Bush Unveils Latest Blueprint for Handling Bird Flu Pandemic 3
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use....
Used when establishing a percutaneous tract for nephrostomy drainage. The guide has a stiff shaft and a gradual transition to a very flexible distal tip. Supplied sterile in peel-open packages. Inten...
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use....
Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: